The European Thyroid Journal, published by BIOSCIENTIFICA LTD, is a premier open-access journal that has been delivering high-quality research in the field of endocrinology since its inception. With an ISSN of 2235-0640 and an E-ISSN of 2235-0802, this journal serves as a vital resource for researchers, clinicians, and students focused on the latest developments in thyroid disease, diagnosis, and treatment. Located in Switzerland and currently enjoying a Q2 ranking in the Endocrinology, Diabetes, and Metabolism category for 2023, it ranks an impressive 71st out of 244 journals in its field, underscoring its significant impact, as evidenced by its substantial impact factor. The journal’s commitment to open access since 2022 enhances its accessibility and reach, ensuring that groundbreaking findings are disseminated swiftly and widely. By bridging knowledge across the endocrine research community, the European Thyroid Journal plays an instrumental role in advancing the understanding and management of thyroid-related disorders, making it an invaluable asset for anyone involved in this critical area of health.

CLINICAL ENDOCRINOLOGY, published by Wiley, is a premier journal in the field of endocrinology, providing a vital platform for the dissemination of cutting-edge research and advancements in the diagnosis and treatment of endocrine disorders. Since its inception in 1972, this prestigious journal has maintained its commitment to excellence with its scope encompassing diverse areas within endocrinology, diabetes, and metabolism, evidenced by its impressive ranking in the Q2 quartile for these categories as of 2023. With a growing impact factor, it serves as a leading reference for researchers and healthcare professionals dedicated to improving patient outcomes. Although the journal does not currently offer open access, it remains accessible through institutional subscriptions, ensuring that vital research reaches an expansive audience. Its robust focus on clinical applications makes CLINICAL ENDOCRINOLOGY an essential resource for anyone involved in the evolving field of endocrinology, thereby underscoring its importance in shaping future research and practice in healthcare.

Bone Reports is a premier, peer-reviewed journal published by Elsevier that has been committed to advancing the field of orthopedics, sports medicine, and endocrinology since its inception as an open-access journal in 2015. With an ISSN of 2352-1872, this esteemed publication seeks to disseminate high-quality research that spans a diverse array of topics related to bone health, metabolic diseases, and musculoskeletal disorders. The journal boasts an impressive impact factor, contributing significantly to its recognition, with a Q2 ranking in Orthopedics and Sports Medicine and a Q3 ranking in Endocrinology, Diabetes, and Metabolism as of 2023. This open-access model enhances accessibility and engagement, allowing researchers, professionals, and students alike to stay at the forefront of developments in these critical areas. With an emphasis on rigorous methodology and innovative findings, Bone Reports is poised to become a vital resource for anyone interested in the latest advances in bone research and clinical applications.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, published by the Endocrine Society, stands as a premier academic journal within the field of endocrinology, diabetes, and metabolism. With a legacy spanning from 1941 to 2024, this journal is distinguished by its significant impact factor, ranking in the Q1 category across multiple related disciplines including biochemistry, clinical biochemistry, and medicine. This esteemed journal, ISSN 0021-972X and E-ISSN 1945-7197, is backed by rigorous peer review, ensuring the publication of high-quality research that contributes to the advancement of clinical practices and scientific knowledge. With a commendable Scopus ranking, positioned in the top percentile of multiple categories, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM serves as an essential resource for researchers, professionals, and students who seek to stay informed about the latest findings and innovations in endocrine research. The journal enriches the existing body of knowledge and fosters discussion among scholars and practitioners alike, solidifying its crucial role in the ongoing discourse in endocrinology and metabolic health.

GYNECOLOGICAL ENDOCRINOLOGY is a prestigious open-access journal published by Taylor & Francis Ltd, focusing on the dynamic fields of endocrinology, obstetrics, and gynecology. With its ISSN of 0951-3590 and E-ISSN of 1473-0766, this journal provides a vital platform for the dissemination of high-quality research and advancements in gynecological endocrinology since its inception in 1987. Notably, it attained an Open Access status in 2023, enhancing its reach and accessibility to researchers and practitioners worldwide. The journal is renowned for its rigorous peer-review process and holds significant standing with a Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Endocrinology, Diabetes, and Metabolism, as of 2023. It is indexed with commendable Scopus ranks in various medical domains, offering a reliable resource for current methodologies and future directions in gynecological health. With the growing emphasis on women's health and endocrinological research, GYNECOLOGICAL ENDOCRINOLOGY serves as an essential repository for innovative studies, clinical insights, and emerging therapeutic strategies, making it an invaluable resource for researchers, clinicians, and students alike.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is a leading peer-reviewed journal published by Wiley, renowned for its commitment to advancing the field of ophthalmology. With an impressive impact factor reflecting its high-quality research contributions, this journal is ranked in the Q1 category both in Medicine (miscellaneous) and Ophthalmology, signifying its crucial role in shaping contemporary ophthalmic research. It boasts a remarkable position in the Scopus Ranks, standing at Rank #13 out of 137 in the field of Medicine and Ophthalmology, placing it within the 90th percentile among its peers. Having been in circulation since 1979, this journal encompasses a broad scope of topics that aim to disseminate groundbreaking findings and stimulate dialogue among researchers, clinicians, and students alike. It is easily accessible to a global audience, embodying the principles of open access, making valuable research available to all. For anyone seeking to stay at the forefront of ophthalmology, CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is an indispensable resource that fosters knowledge and innovation in the ever-evolving landscape of eye care.

ACTA BIOCHIMICA POLONICA (ISSN: 0001-527X, E-ISSN: 1734-154X) is a distinguished journal published by the ACTA BIOCHIMICA POLONICA in Poland, with a rich history dating back to 1955. As a prominent platform for disseminating research, it currently holds a Category Quartile of Q3 in the fields of Biochemistry, Genetics, and Molecular Biology, reflecting its commitment to advancing knowledge in these critical areas. This journal is indexed in Scopus, ranking 124 out of 221, placing it in the 44th percentile among general biochemistry, genetics, and molecular biology journals. Although it does not operate under an open-access model, ACTA BIOCHIMICA POLONICA remains a vital resource for researchers, professionals, and students seeking to delve into the latest developments and discoveries in biochemistry and molecular biology. Its strategic focus on contemporary topics ensures that it plays an essential role in shaping future scientific inquiries and fostering collaboration across various disciplines.

Journal of Neuromuscular Diseases, published by IOS PRESS, is a leading platform dedicated to advancing the field of neurology and neuromuscular research. With a focus on delivering high-quality, peer-reviewed content, this journal aims to foster knowledge sharing and collaboration among researchers, clinicians, and healthcare professionals dealing with neuromuscular disorders. The journal boasts a commendable impact factor within its respective categories, achieving Q2 rankings in both Neurology and Clinical Neurology as of 2023. Spanning from its inception in 2014 to the anticipated convergence in 2024, it is recognized for its contributions to critical discussions in the field, evidenced by its rankings of #145 out of 400 in clinical neurology and #75 out of 192 in neuroscience. As an open access journal, it facilitates wider accessibility of research findings, catering to an audience eager for innovative approaches and developments. Set against the backdrop of the vibrant academic scene in the Netherlands, the Journal of Neuromuscular Diseases serves as an essential resource for driving forward the boundaries of knowledge in neuromuscular-related conditions.

CLINICAL GENETICS is a premier journal in the field of genetics, published by Wiley, and is renowned for advancing the understanding of genetic disorders and their clinical applications. With a notable impact factor and ranking in the top quartile (Q1) in both general genetics and clinical genetics as of 2023, this journal is instrumental for researchers, professionals, and students seeking to explore groundbreaking studies and developments in genetics. Since its inception in 1970, CLINICAL GENETICS has continued to publish high-quality, rigorously peer-reviewed research that pushes the boundaries of knowledge in clinical genetics. The journal maintains a strong reputation in its field, currently holding significant positions in Scopus rankings, including 30th out of 99 in clinical genetics, underscoring its relevance and impact in the field. For those interested, the journal's website provides comprehensive access options for current and archived research, making it an essential resource for anyone involved in genetic research and its clinical application.

European Journal of Medical Genetics, published by Elsevier, is a pivotal platform dedicated to advancing knowledge in the fields of medical genetics and its clinical applications. With an ISSN of 1769-7212 and an E-ISSN of 1878-0849, this journal fosters innovative research and insights into the genetic factors that influence human health. Ranked in the Q3 category for both Genetics and Clinical Genetics, and achieving notable recognition in Medicine (miscellaneous) with a Q2 positioning, it strives to bridge the gap between laboratory findings and clinical practice. Operating in an Open Access format, the journal aims at maximally disseminating essential findings to researchers, professionals, and students alike, ensuring that critical advances in genetics are accessible to the global medical community. With converged publication years spanning from 2005 to 2024, the journal strengthens its mission to be at the forefront of genetic research that informs clinical methodologies and fosters improved healthcare outcomes.